THE Therapeutic Goods
Administration has released new
Public Assessment Reports for
prescription medicines covering
bevacizumab (Avastin), pazopanib
hydrochloride (Votrient) and
predinsone (Lodotra) - tga.gov.au.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 23 Jul 13 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 Jul 13
THE Australian Competition and Consumer Commission (ACCC) has given the green light to the proposed merger of Arrow and Apotex (PD 10 May 2018), finding that the transaction “will not substantially lessen competition in any market”.
NEGOTIATIONS between the Pharmacy Guild of Australia and the Health Department have seen the release of amendments to the Pharmacy Location Rules (PD breaking news), with Health Minister Greg Hunt signing an Amending Determination this week to enact the new arrangements.